S. Kevin Li

Prof. S. Kevin Li

Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2017 in Mycoses
Verified
Journal Article
Closed access
PDF file
SBSudhir Baswan
Sudhir Baswan
GKGerald B. Kasting
Gerald B. Kasting
SLS. Kevin Li
S. Kevin Li
RWRandy Wickett
Randy Wickett
BABrian Adams
Brian Adams
RSRyan Schamper
Ryan Schamper

1 January 2019 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
JHJinsong Hao
Jinsong Hao
SLS. Kevin Li
S. Kevin Li

13 November 2009 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
SISarah A. Ibrahim
Sarah A. Ibrahim
SLS. Kevin Li
S. Kevin Li

25 January 2016 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
JHJinsong Hao
Jinsong Hao
PGPriyanka Ghosh
Priyanka Ghosh
SLS. Kevin Li
S. Kevin Li
BNBryan Newman
Bryan Newman
GKGerald B. Kasting
Gerald B. Kasting
SRSam G. Raney
Sam G. Raney
Introduction: Exposure to heat can impact the clinical efficacy and/or safety of transdermal and topical drug products. Understanding these heat effects and designing meaningful in vitro and in viv...

1 January 2018 in Journal of Dermatological Science
Verified
Journal Article
Closed access
PSPhillip Simmers
Phillip Simmers
SLS. Kevin Li
S. Kevin Li
GKGerald Kasting
Gerald Kasting
JHJason Heikenfeld
Jason Heikenfeld

1 April 2013 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
HLHongzhuo Liu
Hongzhuo Liu
JHJinsong Hao
Jinsong Hao
SLS. Kevin Li
S. Kevin Li
For many years, drug delivery to the inner ear has been a challenge to physicians in the treatment of inner ear disorders. In the past decade, the field of inner ear drug delivery has emerged with the development of new biomaterials and drug delivery technologies to improve the effectiveness of inner ear drug therapy. This paper reviews a number of inner ear drug delivery strategies including systemic, intratympanic, and intracochlear delivery. A focus of this review is the recent advances in intratympanic delivery of medications; approaches utilizing novel biomaterials as well as other recent developments are also discussed. Biotechnology-based approaches, such as gene and stem cell therapy methods are also reviewed. Among the various strategies, local drug delivery approaches including intratympanic and intracochlear drug delivery methods that limit systemic exposure are particularly promising. These inner ear drug delivery systems provide a new opportunity to improve the treatment of inner ear disorders